Back to Search
Start Over
Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme
- Source :
- Sjølie, A K, Klein, R, Porta, M, Orchard, T, Fuller, J, Parving, H H, Bilous, R, Aldington, S & Chaturvedi, N 2011, ' Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme ', Diabetic Medicine, vol. 28, no. 3, pp. 345-351 . https://doi.org/10.1111/j.1464-5491.2010.03210.x
- Publication Year :
- 2011
-
Abstract
- Diabet. Med. 28, 345–351 (2011) Abstract Objective To study the association between baseline retinal microaneurysm score and progression and regression of diabetic retinopathy, and response to treatment with candesartan in people with diabetes. Methods This was a multicenter randomized clinical trial. The progression analysis included 893 patients with Type 1 diabetes and 526 patients with Type 2 diabetes with retinal microaneurysms only at baseline. For regression, 438 with Type 1 and 216 with Type 2 diabetes qualified. Microaneurysms were scored from yearly retinal photographs according to the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. Retinopathy progression and regression was defined as two or more step change on the ETDRS scale from baseline. Patients were normoalbuminuric, and normotensive with Type 1 and Type 2 diabetes or treated hypertensive with Type 2 diabetes. They were randomized to treatment with candesartan 32 mg daily or placebo and followed for 4.6 years. Results A higher microaneurysm score at baseline predicted an increased risk of retinopathy progression (HR per microaneurysm score 1.08, P
- Subjects :
- Adult
Male
medicine.medical_specialty
Endocrinology, Diabetes and Metabolism
Tetrazoles
law.invention
Endocrinology
Randomized controlled trial
Retinal Diseases
law
Predictive Value of Tests
Internal medicine
Diabetes mellitus
Internal Medicine
medicine
Humans
Hypoglycemic Agents
Microaneurysm
Diabetic Retinopathy
Surrogate endpoint
business.industry
Biphenyl Compounds
Remission Induction
Diabetic retinopathy
Middle Aged
medicine.disease
Aneurysm
Surgery
Regression, Psychology
Candesartan
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Predictive value of tests
Disease Progression
Benzimidazoles
Female
business
Angiotensin II Type 1 Receptor Blockers
Retinopathy
medicine.drug
Subjects
Details
- ISSN :
- 14645491
- Volume :
- 28
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Diabetic medicine : a journal of the British Diabetic Association
- Accession number :
- edsair.doi.dedup.....088e1b3d574a8b50cc807b046bad71f0